Lidocaine 5% Plasters (Versatis® 5%) in Pediatric Neuropathic Pains and Vasoocclusive Sickle Cell Crisis Pains
Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
Lidocaine 5% plaster (VERSATIS® 5%) showed its efficacy and safety in the post-herpetic
zoster adult pains. This treatment is recommended in first intention in adult neuropathic
pains with allodynia.
The purpose of this study is to assess efficacy and safety of lidocaine 5% plaster (VERSATIS®
5%) in the pediatric neuropathic pains and vasoocclusive sickle cell crises pains.